CAT# | CPM-1-0763 |
Sequence | AAGIGILTV |
Size | 100 test | Storage | 4 ̊C | Epitope Origin | MART1 27 | MHC Restriction | HLA-A_02_01 | Conjugate | PE |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
CPM-1-0275 | HLA-A_02_01 Mtb Ag85A48-56 tetramer-GLPVEYLQV-PE labeled | Inquiry | ||
CPM-1-0324 | HLA-A_24_02 Influenza PB1482-490 tetramer-SYINRTGTF-PE labeled | Inquiry | ||
CPM-1-0132 | HLA-A_11_01 EBV LMP2 tetramer-SSCSSCPLSK-PE labeled | Inquiry | ||
CPM-1-0320 | HLA-A_24_02 LY6K tetramer-RYCNLEGPPI-APC labeled | Inquiry | ||
CPM-1-0427 | HLA-A_24_02 LY6K tetramer-RYCNLEGPPI-BV421 labeled | Inquiry |
CAT# | Product Name | M.W | Molecular Formula | Inquiry |
---|---|---|---|---|
10-101-20 | Goserelin Acetate | 1269.43 | C59H84N18O14 | Inquiry |
10-101-59 | Liraglutide | 3751.2 | C172H265N43O51 | Inquiry |
R1574 | Octreotide | 1019.24 | C₄₉H₆₆N₁₀O₁₀S₂ | Inquiry |
10-101-139 | Myrcludex B | Inquiry | ||
10-101-285 | Teduglutide | 3752.08 | C164H252N44O55S | Inquiry |
R1847 | Sermaglutide | 4114 | C187H291N45O59 | Inquiry |
R1961 | Carbetocin | 988.2 | C45H69N11O12S | Inquiry |
Required fields are marked with *
×Required fields are marked with *
×* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
Ecallantide, sold under the trade name Kalbitor, is a plasma kallikrein inhibitor, consisting of sixty amino aci ...
Ramoplanin is a new kind of glycopeptide antibiotics, which can inhibit the biosynthesis of the cell walls of gr ...
DAPTA (D-[Ala]-Ser-Thr-Thr-Thr-Asn-Tyr-Thr-amide), D-Ala-Peptide T amide, is one of analogue of peptide T, which ...
Gap 19 is a nonapeptide derived from the cytoplasmic loop (CL) of Connexin-43 (Cx43). Cx43 is a predominant card ...
Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...